Physician profile
David A Cox
NPI 1558307181
$1,031.35
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $192 · 2021: $403 · 2022: $375 · 2024: $61.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $233.34 | 2020-2022 | |
| Novo Nordisk INC | $219.76 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $136.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $97.02 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.67 | 2022 | |
| Atricure, INC. | $48.00 | 2024 | |
| Sanofi-Aventis U.S. LLC | $41.79 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $36.99 | 2022 | |
| Amarin Pharma, INC. | $31.20 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $30.77 | 2020-2021 | |
| Dexcom, INC. | $23.39 | 2022 | |
| Esperion Therapeutics, INC. | $19.71 | 2021 | |
| Eisai INC. | $19.64 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.05 | 2021 | |
| Exact Sciences Corporation | $13.71 | 2024 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.